South and Central America Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment Type (Nicotine Addiction Treatment, Alcohol Addiction Treatment, Opioid Addiction Treatment, Other Substance Addiction Treatment); Drug Type (Varenicline, Bupropion, Nicotine Replacement Products, Buprenorphine, Naltrexone, Disulfiram, Others); Treatment Center (Outpatient Treatment Center, Residential Treatment Center, Inpatient Treatment Center); Distribution Channel (Hospitals, Medical Stores, Others) and Country
Market Introduction
Addiction is a psychological and physical inability to stop consuming drugs, alcohol, opioids, and related category substances, even though those substances have various mental and physical harms. An addiction develops dependency in a person to take that substance. So, to stop addictions, there are several options available such as drug therapy, rehabilitation, which can stop addiction in a better way.
Get more information on this report :
Market Overview and Dynamics
The South and Central America Addictions Therapeutics market is expected to reach US$ 482.04 million in 2027 from US$ 332.54 million in 2019. The market is estimated to grow with a CAGR of 4.9% from 2020 to 2027. The growth of the market is attributed to rising approval of new drugs and launch of digital therapeutics to treat addiction, conduction of various awareness campaigns and government efforts to counteract drug abuse and promote medication. However, high cost associated with drug development is hindering the growth of the addiction therapeutics market.
Key Market Segments
Based on treatment type, the South and Central America addictions therapeutics market is segmented into nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and other substance addiction treatment. In 2019, the nicotine addiction treatment segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period.
The South and Central America addictions therapeutics market, by drug type, is segmented into varenicline, bupropion, nicotine replacement products, buprenorphine, naltrexone, disulfiram, and others. The varenicline segment held the largest market share in 2019. However, the nicotine replacement products segment is anticipated to register the highest CAGR in the market during the forecast period.
By treatment center, the South and Central America addictions therapeutics market is segmented into outpatient treatment center, residential treatment center, and inpatient treatment center. In 2019, the outpatient treatment center segment held the largest market share, and the same segment is estimated to register the highest CAGR in the market during the forecast period.
The South and Central America addictions therapeutics market, based on distribution channel, is segmented into hospital pharmacies, medical stores, and others. The hospital pharmacies segment held the largest share of the market in 2019, and the medical stores segment is estimated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
Some of the primary and secondary sources associated with this report on the South and Central America addictions therapeutics market are Ministry of Health in Argentina (ANMAT); Centers for Disease Control and Prevention (CDC); and World Health Organization (WHO) among others.
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of the South and Central America addictions therapeutics market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the South and Central America addictions therapeutics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the South and Central America addictions therapeutics market.
SOUTH AND CENTRAL AMERICA ADDICTIONS THERAPEUTICS MARKET SEGMENTATION
By Treatment Type
- Opioid Addiction Treatment
- Alcohol Addiction Treatment
- Nicotine Addiction Treatment
- Other Substance Addiction Treatment
- Buprenorphine
- Naltrexone
- Bupropion
- Disulfiram
- Nicotine Replacement Products
- Varenicline
- Others
- Inpatient Treatment Center
- Residential Treatment Center
- Outpatient Treatment Center
- Hospital Pharmacies
- Medical stores
- Others
By Country
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Indivior PLC
- GlaxoSmithKline plc
- Bausch Health Companies Inc
- Cipla Inc.
- Hikma Pharmaceuticals PLC
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South and Central America Addictions Therapeutics Market – By Treatment Type
1.3.2 South and Central America Addictions Therapeutics Market – By Drug Type
1.3.3 South and Central America Addictions Therapeutics Market – By Treatment Center
1.3.4 South and Central America Addictions Therapeutics Market – By Distribution Channel
1.3.5 South and Central America Addictions Therapeutics Market – By Country
2. Addictions Therapeutics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Addiction Therapeutics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South and Central America (SCAM) – PEST Analysis
5. Addiction Therapeutics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Addiction Among General Populace
5.1.2 Conduction of Awareness Campaigns
5.2 Market Restraint
5.2.1 Steeping Costs of Drug Development
5.3 Market Opportunity
5.3.1 Rising Demand for R&D from Contract Organizations
5.4 Future Trend
5.4.1 Consistent Launch of Therapeutics
5.5 Impact Analysis
6. Addiction Therapeutics Market – South and Central America Analysis
6.1 South and Central America Addictions Therapeutics Marker Revenue Forecast and Analysis
7. Addictions Therapeutics Market– Treatment Type
7.1 Overview
7.2 Addictions Therapeutics Market Share, Treatment Type, 2019 and 2027 (%)
7.3 Nicotine Addiction Treatment
7.3.1 Overview
7.3.1.1 Nicotine Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
7.4 Alcohol Addiction Treatment
7.4.1 Overview
7.4.1.1 Alcohol Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
7.5 Opioid Addiction Treatment
7.5.1 Overview
7.5.1.1 Opioid Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
7.6 Other Substance Addiction Treatment
7.6.1 Overview
7.6.2 Other Substance Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8. Addictions Therapeutics Market– Drug Type
8.1 Overview
8.2 Addictions Therapeutics Market Share, Drug Type, 2019 and 2027 (%)
8.3 Varenicline
8.3.1 Overview
8.3.1.1 Varenicline: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8.4 Bupropion
8.4.1 Overview
8.4.1.1 Bupropion: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8.5 Nicotine Replacement Products
8.5.1 Overview
8.5.1.1 Nicotine Replacement Products: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8.6 Buprenorphine
8.6.1 Overview
8.6.1.1 Buprenorphine: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8.7 Naltrexone
8.7.1 Overview
8.7.1.1 Naltrexone: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8.8 Disulfiram
8.8.1 Overview
8.8.1.1 Disulfiram: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8.9 Others
8.9.1 Overview
8.9.1.1 Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
9. Addictions Therapeutics Market– Treatment Center
9.1 Overview
9.2 Addictions Therapeutics Market Share, Treatment Center, 2019 and 2027 (%)
9.3 Outpatient Treatment Center
9.3.1 Overview
9.3.1.1 Outpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
9.4 Residential Treatment Center
9.4.1 Overview
9.4.1.1 Residential Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
9.5 Inpatient Treatment Center
9.5.1 Overview
9.5.1.1 Inpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
10. Addictions Therapeutics Market– Distribution Channel
10.1 Overview
10.2 Addictions Therapeutics Market Share, Distribution Channel, 2019 and 2027 (%)
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.1.1 Hospital Pharmacies: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
10.4 Medical Stores
10.4.1 Overview
10.4.1.1 Medical Stores: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
10.5 Others
10.5.1 Overview
10.5.1.1 Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
11. Addiction Therapeutics Market Analysis and Forecasts To 2027 – South and Central America Analysis
11.1 South and Central America: Addiction Therapeutics Market
11.1.1 Overview
11.1.2 South and Central America: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.3 South and Central America Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)
11.1.4 South and Central America Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
11.1.5 South and Central America Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)
11.1.5.1 South and Central America: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.6 South and Central America: Addiction Therapeutics Market, by Country, 2019 & 2027 (%)
11.1.7 Brazil: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.7.1 Brazil: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.7.2 Brazil Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)
11.1.7.3 Brazil Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
11.1.7.4 Brazil Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)
11.1.7.5 Brazil: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.8 Argentina: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 Argentina: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 Argentina Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)
11.1.8.3 Argentina Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
11.1.8.4 Argentina Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027(USD Million)
11.1.8.5 Argentina: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.9 Rest of South and Central America: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Rest of South and Central America: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Rest of South and Central America Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)
11.1.9.3 Rest of South and Central America Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
11.1.9.4 Rest of South and Central America Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)
11.1.9.5 Rest of South and Central America Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027(USD Million)
12. Impact of COVID-19 Pandemic on South and Central America Addiction Therapeutics Market
12.1 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Company Profiles
13.1 Indivior PLC
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Pfizer Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bausch Health Companies Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Cipla Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Hikma Pharmaceuticals PLC
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)
Table 2. South and Central America Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 3. South and Central America Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)
Table 4. South and Central America: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. Brazil Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)
Table 6. Brazil Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 7. Brazil Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)
Table 8. Brazil: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. Argentina Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)
Table 10. Argentina Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 11. Argentina Addiction Therapeutics Market, Drug Type – Revenue and Forecast to 2027(USD Million)
Table 12. Argentina: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Rest of South and Central America Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)
Table 14. Rest of South and Central America Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 15. Rest of South and Central America Addiction Therapeutics Market, Treatment Center – Revenue and Forecast to 2027(USD Million)
Table 16. Rest of South and Central America Addiction Therapeutics Market, Distribution Channel – Revenue and Forecast to 2027(USD Million)
Table 17. Glossary of Terms, Medical Adhesive and Sealants Market
LIST OF FIGURES
Figure 1. Addictions Therapeutics Market Segmentation
Figure 2. Addictions Therapeutics Market – By Country
Figure 3. Addictions Therapeutics Market Overview
Figure 4. Nicotine Addiction Treatment Segment Held Largest Share of Addictions Therapeutics Market
Figure 5. South and Central America Addictions Therapeutics Market – Leading Country Markets (US$ Million)
Figure 6. South and Central America (SCAM) PEST Analysis
Figure 7. Addiction Therapeutics Market Impact Analysis of Drivers and Restraint
Figure 8. South and Central America Addictions Therapeutics Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. Addictions Therapeutics Market Share, Treatment Type, 2019 and 2027 (%)
Figure 10. Nicotine Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 11. Alcohol Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 12. Opioid Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 13. Other Substance Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 14. Addictions Therapeutics Market Share, Drug Type, 2019 and 2027 (%)
Figure 15. Varenicline: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 16. Bupropion: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 17. Nicotine Replacement Products: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 18. Buprenorphine: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 19. Naltrexone: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 20. Disulfiram: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 21. Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 22. Addictions Therapeutics Market Share, Treatment Center, 2019 and 2027 (%)
Figure 23. Outpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 24. Residential Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 25. Inpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 26. Addictions Therapeutics Market Share, Distribution Channel, 2019 and 2027 (%)
Figure 27. Hospital Pharmacies: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 28. Medical Stores: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 29. Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 30. South and Central America: Addiction Therapeutics Market, by Key Country – Revenue (2019) (USD Million)
Figure 31. South and Central America Addiction Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 32. South and Central America: Addiction Therapeutics Market, by Country, 2019 & 2027 (%)
Figure 33. Brazil: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Argentina: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Rest of South and Central America: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Impact Of COVID-19 Pandemic in South and Central America Countries Market
- Indivior PLC
- GlaxoSmithKline plc
- Bausch Health Companies Inc
- Cipla Inc.
- Hikma Pharmaceuticals PLC
- Determine prospective investment areas based on a detailed trend analysis of the South and Central America addictions therapeutics market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the South and Central America addictions therapeutics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the South and Central America addictions therapeutics market.